Loading…
Bliss GVS Pharma (BLISSGVS)₹654.75+4.89%Pharmaceuticals
Bliss GVS Pharma is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 43.0 against a peer median of 29.9, and ROCE of 17.0% against a peer median of 15.0%, and latest-quarter sales growth of 28.1% against a peer median of 28.1%. By market cap it is #4 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aarti Pharmalabs | 8,357 | 32.4 | 11.1 | 8.6 | 0.36 | 0.4 | 1,816 | 175 | 46.0 | 153.8 | vs BLISSGVS |
| Sanofi Consumer Healthcare India | 7,933 | 29.9 | 90.0 | 71.6 | 0.06 | 2.2 | 876 | 240 | 6.9 | 13.2 | vs BLISSGVS |
| Sanofi India | 7,657 | 23.6 | 58.1 | 43.0 | 0.02 | 3.7 | 1,842 | 327 | 7.9 | 19.9 | vs BLISSGVS |
| Bliss GVS Pharma | 6,947 | 43.0 | 17.0 | 11.8 | 0.02 | 0.2 | 925 | 135 | 28.1 | 82.7 | — |
| Sun Pharma Advanced Research Company | 6,830 | 4.3 | 164.1 | 278.9 | 0.42 | 0.0 | 1,882 | 1,556 | 299.7 | — | vs BLISSGVS |
| FDC | 6,425 | 20.6 | 15.0 | 11.3 | 0.01 | 1.3 | 2,173 | 282 | 20.8 | 74.8 | vs BLISSGVS |
| Innova Captab | 6,118 | 39.9 | 15.0 | 13.7 | 0.32 | 0.2 | 1,627 | 141 | 33.8 | 42.0 | vs BLISSGVS |
| IOL Chemicals and Pharmaceuticals | 5,967 | 29.4 | 11.1 | 8.4 | 0.08 | 0.5 | 2,312 | 138 | 40.1 | 116.5 | vs BLISSGVS |
| Morepen Laboratories | 5,433 | 29.2 | 8.0 | 5.3 | 0.17 | 0.2 | 1,808 | 96 | 80.9 | 117.0 | vs BLISSGVS |
| Senores Pharmaceuticals | 5,417 | 40.6 | 15.0 | 13.5 | 0.37 | 0.0 | 632 | 122 | 18.6 | 23.4 | vs BLISSGVS |
| Orchid Pharma | 5,291 | 421.0 | 2.0 | 1.3 | 0.28 | 0.0 | 1,229 | 10 | 15.5 | — | vs BLISSGVS |
| Peer median | 6,425 | 29.9 | 15.0 | 11.8 | 0.17 | 0.2 | 1,808 | 141 | 28.1 | 74.8 |
Listed companies closest to Bliss GVS Pharma in Pharmaceuticals include Aarti Pharmalabs, Sanofi Consumer Healthcare India, Sanofi India, Sun Pharma Advanced Research Company, FDC, Innova Captab, IOL Chemicals and Pharmaceuticals, Morepen Laboratories.
Aarti Pharmalabs, with a market cap of ₹8,357 Cr.
Bliss GVS Pharma trades at a P/E of 43.0; the median of its peer set is 29.9. A P/E above or below the median is a description, not a judgement on value.
Bliss GVS Pharma's return on capital employed is 17.0%, above the peer median of 15.0%.